That trial, CedLara, was discontinued in June 2022: a pre-specified interim analysis conducted at roughly half of target enrolment concluded that the number of additional patients required to demonstrate a statistically significant effect was too large to justify continuing
Secure checkout with multiple payment options
For the full procedure and needle depth selection, see our GHK-Cu microneedling guide
Key Benefits: Supports soft tissue and joint resilience Helps maintain gastrointestinal comfort and mucosal integrity Promotes nitric oxide and redox balance Utilizes LipoEmulsion technology for ingredient stability Precision spray delivery for consistent dosing How It Works: BPC-Lx Pro delivers a calibrated pentadecapeptide as short-chain amino acids suspended in a lipid-based LipoEmulsion system
Angiogenesis Studies: Angiogenic potential investigated through multiple assays: HUVEC tube formation (network complexity), endothelial migration (cells/field), aortic ring sprouting (sprout length/number), VEGF/VEGFR2 expression (qPCR, Western blot), CAM assay (vessel density)